Back
Cellectis SA 10K Form
Buy
79
CLLS
Cellectis SA
Last Price:
2.03
Seasonality Move:
2.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLLS News And Ratings
See the #1 stock for the next 7 days that we like better than CLLS
CLLS Financial Statistics
Sales & Book Value
| Annual Sales: | $755K |
|---|---|
| Cash Flow: | $-6.63M |
| Price / Cash Flow: | 3.18 |
| Annual Sales: | $1.29 |
| Price / Book: | 1.66 |
Profitability
| EPS (TTM): | -1.34000 |
|---|---|
| Net Income (TTM): | $-84.48M |
| Gross Margin: | $18K |
| Return on Equity: | -79.78% |
| Return on Assets: | -24.83% |
Cellectis SA Earnings Forecast
Key Cellectis SA Financial Ratios
- The Gross Profit Margin over the past 17 years for CLLS is 2.38%.
- The Selling, General & Administrative Expenses for CLLS have been equal to 2,226.75% of Gross Profit Margin.
- The Research & Development expenses have been 11,608.74% of Revenue.
- The Interest Expense is -5.25% of Operating Income.
- The Net Earning history of CLLS is -13,385.30% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 6 years.
Cellectis SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLLS |
| CUSIP: | 15117K |
| Website: | cellectis.com |
Debt
| Debt-to-Equity Ratio: | 0.36 |
|---|---|
| Current Ratio: | 1.78 |
| Quick Ratio: | 1.74 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLLS Technical Analysis vs Fundamental Analysis
Buy
79
Cellectis SA (CLLS)
is a Buy
Is Cellectis SA a Buy or a Sell?
-
Cellectis SA stock is rated a Buy
The current Cellectis SA [CLLS] share price is $2.14. The Score for CLLS is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.